Advertisement

Psychopharmacology

, Volume 86, Issue 4, pp 417–425 | Cite as

Buprenorphine effects on cigarette smoking

  • Nancy K. Mello
  • Scott E. Lukas
  • Jack H. Mendelson
Original Investigations

Abstract

Cigarette smoking increased during administration of buprenorphine, an opioid mixed agonist-antagonist, in comparison to drug-free baseline in seven heroin addicts maintained on buprenorphine for 24 days (P<0.01–0.001). Ascending buprenorphine doses (0.5–8.0 mg/day) were associated with significant increases in cigarette smoking at doses of 2.0 mg/day sc and above. Cigarette smoking during 10 days of buprenorphine maintenance at 8 mg/day was significantly higher than during the buprenorphine induction phase (P<0.01). Six subjects given placebo buprenorphine over 14 days showed no change in cigarette smoking. The placebo group self-administered heroin for 10 days, and cigarette smoking increased significantly during heroin use (P<0.001). The rate of cigarette smoking defined by intercigarette intervals was highest during the 10 days of high-dose buprenorphine maintenance or placebo plus heroin self-administration. Both groups requested significantly more cigarettes at intervals of 0–10, 11–20, and 21–30 min than during the drug-free baseline. These data confirmed previous findings that opioid agonist administration is associated with increased cigarette smoking and suggest that buprenorphine has primarily agonist effects on cigarette smoking.

Key words

Buprenorphine Opioid mixed agonist-antagonist Cigarette smoking Tobacco smoking Buprenorphine effects on cigarette smoking Heroin addiction Polydrug use 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Armitage AK (1978) The role of nicotine in the tobacco smoking habit. In: Thornton RE (ed) Smoking behavior. Churchill Livingstone, Edinburgh, pp 229–258Google Scholar
  2. Bigelow GE, Stitzer ML, Griffiths RR, Liebson IA (1981) Human methadone detoxification: Opioid self-administration behavior, cigarette smoking and withdrawal signs and symptoms as a function of progressive dose reductions. Fed Proc 40:296Google Scholar
  3. Chait LD, Griffiths RR (1983) Effects of caffeine on cigarette smoking and subjective response. Clin Pharmacol Ther 34(5):612–622Google Scholar
  4. Chait LD, Griffiths RR (1984) Effects of methadone on human cigarette smoking and subjective ratings. J Pharmacol Exp Ther 229(3):636–640Google Scholar
  5. Chernick V (1983) The brain's own morphine and cigarette smoking: The junkie in disguise? Chest 83:2–3Google Scholar
  6. Cicero TJ, Newman KS, Gerrity M, Schmoeker PF, Bell RD (1982) Ethanol inhibits the naloxone-induced release of luteinizing hormone-releasing hormone from the hypothalamus of the male rat. Life Sci 31:1587–1596Google Scholar
  7. Cicero TJ, Schainker BA, Meyer ER (1979) Endogenous opioids participate in the regulation of the hypothalamic-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone. Endocrinology 104:1286–1291Google Scholar
  8. Ellingboe J, Veldhuis JD, Mendelson JH, Kuehnle JC, Mello NK (1982) Effect of endogenous opioid blockade on the amplitude and frequency of pulsatile luteinizing hormone secretion in normal men. J Clin Endocrinol Metab 54(4):854Google Scholar
  9. Emrich HM, Nusselt L, Gramsch C, John S (1983) Heroin addiction: β-Endorphin immunoreactivity in plasma increases during withdrawal. Pharmacopsychiatria 16:93–96Google Scholar
  10. Griffiths RR, Bigelow GE, Liebson I (1976) Facilitation of human tobacco self-administration by ethanol: A behavioral analysis. J Exp Anal Behav 25(3):279–292Google Scholar
  11. Griffiths RR, Henningfield JE, Bigelow GE (1982) Human cigarette smoking: Manipulation of number of puffs per bout, interbout interval and nicotine dose. J Pharmacol Exp Ther 220(2):256–265Google Scholar
  12. Gritz ER (1980) Smoking behavior and tobacco use. In: Mello NK (ed) Advances in substance abuse, behavioral and biological research, vol. 1. JAI Press, Greenwich, pp 91–158Google Scholar
  13. Henningfield JE, Griffiths RR (1981) Cigarette smoking and subjective response: Effects of d-amphetamine. Clin Pharmacol Ther 30(4):497–505Google Scholar
  14. Henningfield JE, Chait LD, Griffiths RR (1983) Cigarette smoking and subjective response in alcoholics: Effects of pentobarbital. Clin Pharmacol Ther 33:806–812Google Scholar
  15. Henningfield JE, Chait LD, Griffiths RR (1984) Effects of ethanol on cigarette smoking by volunteers without histories of alcoholism. Psychopharmacology 82:1–5Google Scholar
  16. Houde RW (1979) Analgesic effectiveness of the narcotic agonistantagonists. Br J Clin Pharmacol (supl 3) 7:297–308Google Scholar
  17. Jaffe JH, Jarvik ME (1978) Tobacco use and tobacco use disorder. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: A generation of progress. Raven, New York, pp 1665–1676Google Scholar
  18. Jarvik ME, Cullen JW, Gritz ER, Vogt TM, West LJ (eds) (1977) Research on smoking behavior, NIDA monogr 17. US Gov Printing Office, Washington, DC, p 381Google Scholar
  19. Jasinski DR, Pevnick JS, Griffith JD (1978) Human pharmacology and abuse potential of the analgesic buprenorphine. Arch Gen Psychiatry 35:601–616Google Scholar
  20. Jusko WV (1978) Role of tobacco smoking in pharmacokinetics. J Pharmacokinet Biopharm 6(1):7–39Google Scholar
  21. Karras A, Kane JM (1980) Naloxone reduces cigarette smoking. Life Sci 27:1441–1445Google Scholar
  22. Kozlowski LT (1976) Effects of caffeine consumption on nicotine consumption. Psychopharmacology 47:165–168Google Scholar
  23. Lewis J, Rance MJ, Sanger DJ (1983) The pharmacology and abuse potential of buprenorphine, a new antagonist analgesic. In: Mello NK (ed) Advances in substance abuse, behavioral and biological research, vol 3. JAI Press, Greenwich, pp 103–154Google Scholar
  24. Lukas SE, Jasinski DR, Johnson RE (1984) Electroencephalographic and behavioral correlates of buprenorphine administration. Clin Pharmacol Ther 36:127–132Google Scholar
  25. Mello NK (1977) Stimulus self-administration: Some implications for the prediction of drug abuse liability. In: Thompson T, Unna KR (eds) Predicting dependence liability of stimulant and depressant drugs. University Park, Baltimore, pp 159–173Google Scholar
  26. Mello NK (1978) Control of drug self-administration: The role of aversive consequences. In: Peterson RC, Stillman RC (eds) Phencyclidine abuse: An appraisal. NIDA Monogr Res Ser no 21, Rockville, pp 289–308Google Scholar
  27. Mello NK (1983) A behavioral analysis of the reinforcing properties of alcohol and other drugs in man. In: Kissin B, Begleiter H (eds) The pathogenesis of alcoholism, biological factors, vol 7. Plenum, New York, pp 133–198Google Scholar
  28. Mello NK, Mendelson JH (1980) Buprenorphine suppresses heroin use by heroin addicts. Science 27:657–659Google Scholar
  29. Mello NK, Mendelson JH (1985) Operant analysis of human drug self-administration: Marihuana, alcohol, heroin and polydrug use. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs, in pressGoogle Scholar
  30. Mello NK, Mendelson JH, Kuehnle JC (1982) Buprenorphine effects on human heroin self-administration: An operant analysis. J Pharmacol Exp Ther 223(1):30–39Google Scholar
  31. Mello NK, Mendelson JH, Sellers ML, Kuehnle JC (1980a) Effects of alcohol and marihuana on tobacco smoking. Clin Pharmacol Ther 27(2):202–209Google Scholar
  32. Mello NK, Mendelson JH, Sellers ML, Kuehnle JC (1980b) Effects of heroin self-administration on cigarette smoking. Psychopharmacology 67:45–52Google Scholar
  33. Mendelson JH, Ellingboe J, Kuehnle JC, Mello NK (1980) Heroin and naltrexone effects on pituitary gonadal hormones in man: Interaction of steroid feedback effects, tolerance and super-sensitivity. J Pharmacol Exp Ther 214:503–506Google Scholar
  34. Mendelson JH, Mello NK (1975) Plasma testosterone levels during chronic heroin use and protracted abstinence: A study of Hong Kong addicts. Clin Pharmacol Ther 17(5):529–533Google Scholar
  35. Mendelson JH, Mello NK (1982) Hormones and psycho-sexual development in young men following chronic heroin use. Neurobehav Toxicol Teratol 4:441–445Google Scholar
  36. Mendelson JH, Kuehnle JC, Ellingboe J, Babor TF (1974) Plasma testosterone levels before, during, and after chronic marihuana smoking. N Engl J Med 291:1051–1055Google Scholar
  37. Mendelson JH, Mendelson JE, Patch VD (1975a) Plasma testosterone levels in heroin addiction and during methadone maintenance. J Pharmacol Exp Ther 192:211–217Google Scholar
  38. Mendelson JH, Meyers J, Ellingboe J, Mirin SM, McDougle M (1975b) Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther 195:296–305Google Scholar
  39. Mirin SM, Meyer RE, Ellingboe J, Mendelson JH (1979) Effect of opiates on neuroendocrine function: Testosterone and pituitary gonadotropins. In: Meyer RE, Mirin SM (eds) The heroin stimulus. Plenum Press, New York, pp 177–198Google Scholar
  40. Moult PJA, Grossman A, Evans JM, Rees LH, Besser GM (1981) The effect of naloxone on pulsatile gonadotrophin release in normal subjects. Clin Endocrinol 14:321–324Google Scholar
  41. Nemeth-Coslett R, Griffiths RR (1984) Determinants of puff duration in cigarette smokers: I Pharmacol. Biochem. Behav 20:965–971Google Scholar
  42. Nil R, Buzzi R, Battig K (1984) Effects of single doses of alcohol and caffeine on cigarette smoke puffing behavior. Pharmacol Biochem Behav 20:583–590Google Scholar
  43. O'Brien CP, Terenius L, Wahlstrom A, McLellan AT, Krivoy W (1982) Endorphin levels in opioid-dependent human subjects: A longitudinal study. Ann NY Acad Sci 398:377–387Google Scholar
  44. Pomerleau OF, Fertig JB, Seyler LE, Jaffe J (1983) Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81:61–67Google Scholar
  45. Russell MAH (1976) Tobacco smoking and nicotine dependence. In: Gibbins RJ, Israel Y, Kalant H, Popham RE, Schmidt W, Smart RG (eds) Research advances in alcohol and drug problems, John Wiley and Sons, New York, pp 282–295Google Scholar
  46. Schuster CR, Lucchesi BR, Emley GS (1979) The effects of damphetamine, meprobamate, and lobeline on the cigarette smoking behavior of normal human subjects. In: Krasnegor N (ed) Cigarette smoking as a dependence process. US Gov Printing Off, Washington, DC, pp 91–99Google Scholar
  47. Tobin MJ, Jenouri G, Sackner MA (1983) Effect of naloxone on change in breathing pattern with smoking. Chest 82:530–537Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Nancy K. Mello
    • 1
  • Scott E. Lukas
    • 1
  • Jack H. Mendelson
    • 1
  1. 1.Alcohol and Drug Abuse Research CenterHarvard Medical School-McLean HospitalBelmontUSA

Personalised recommendations